Please login to the form below

Advent

This page shows the latest Advent news and features for those working in and with pharma, biotech and healthcare.

UK immunology biotech MiroBio launches with $34m fundraising

MiroBio’s Series A financing was co-led by Oxford Sciences Innovation and Samsara Biocapital, with Advent Life Sciences and SR One also joining the round. ... For the time being MiroBio has four directors – one apiece from each of its backers –

Latest news

Hudson named Brandicourt’s successor as Sanofi’s CEO

deal and selling off its European generics business to private equity group Advent for $2.4bn, whilst implementing a big cost-reduction programme.
Gottlieb admonishes industry for clinical trial failings

Gottlieb – who is leaving the FDA next month and will be replaced on an interim basis by National Cancer Institute (NCI) director Ned Sharpless – says that the advent in precision medicine,
Pfizer’s flat sales focus investor attention on M&A

In the last few weeks Sanofi has sold its European generics business to Advent, GlaxoSmithKline divested its rare disease unit to start-up Orchard Therapeutics after buying Novartis out of a
P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

In the last few weeks Sanofi has sold its European generics business to Advent, GlaxoSmithKline divested its rare disease unit to start-up Orchard Therapeutics after buying Novartis out of a
Sanofi sells European generics to Advent for $2.4bn

The deal will create a new, independent European generics company. Private equity group Advent has agreed a 1.9bn ($2.4bn) deal to buy the European generics unit of French pharma ... Sanofi has been looking to divest the Zentiva generics unit since 2016

More from news
Approximately 3 fully matching, plus 94 partially matching documents found.

Latest Intelligence

Persuasive technology: designing behaviour change initiatives for digital

Advances in technology, with the advent of AI and machine learning, has made it possible to influence behavioural change in a more personalised way.
Staying ahead in the era of precision medicine

In addition to new technologies such as NGS, we are seeing the advent of novel trial designs (such as ‘basket’ trials), and many practising physicians may not understand how to apply
For trials without tribulations, we must improve patient experience

And this massive growth in competition for clinical trials has coincided with the advent of the web and the digital age, which have forever changed the rules of engagement.
Immunotherapy combination trials Q&A

Finally the advent of precision medicine platforms that deploy natural language processing algorithms to interrogate Electronic Health Records in defined site networks is assisting sites to know their patient populations better ... With the advent of the
Behaviour change: what is the buzz all about?

The advent of the ‘informed patient’ for whom social media, in particular, has provided a voice, means that patients have become more central – a positive trend that looks set to increase

More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest from PMHub

Digital Nation: How Australia became a digital health pioneer

With the advent of these technologies and the many benefits they bring, it is of little surprise that governments worldwide are looking to leverage new digital tools to improve the delivery
Spotlight interview: 15 minutes on patient engagement in pharma

Now, with the advent of technology and information being available at everyone’s fingertips, patients are becoming much more informed about different diagnoses, treatments, and which products are effective and ineffective
Turning learning into action: The challenge of behaviour change

Developing meaningful metrics. In addition to the use of evidence-based tools to establish the drivers of and barriers to behavioural change, the advent of digital technology and real-time data
'Fake news': battling misinformation in healthcare

With the advent of the internet and the popularity of new websites, the public expects information instantly.
Artificial Intelligence: a new character in the storytelling of drug development and discovery?

Nevertheless, with the advent of personalised medicine and acquisition of more data that allows us to further understand biochemical pathways, AI may eventually be able to solve these problems as well.

More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Could formulary intelligence be your brand differentiator?: Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
How COVID-19 is accelerating the threat of antimicrobial resistance: Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping: Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...